We discuss the clinical characteristics of ties and Tourette's syndrom
e (TS) and also possible treatment options. Based upon an overview of
published pathophysiological and PET data, and the results of a recent
PET study of changes in opioid receptor binding in TS, we hypothesize
that the disease arises due to dysfunction within the cingulate and o
rbitofrontal cortex. The beneficial effects of dopamine receptor antag
onists and dopamine-depleting agents in TS are suggested to be mediate
d via basal ganglia-thalamo-frontal circuits, while opioid agents may
act directly on the cingulate.